RxDoctor Payments Data

Anjan Patel, MD

Family Medicine · Delray Beach, FLNPI 1255645156

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 144 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. Abbott accounts for 87.0% of it on its own, with 17 other manufacturers making up the rest. Reporting peaked in 2020 at $2,853 and has fallen 92.2% since, to $222 in 2025. Among family medicine clinicians in FL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$8,778in general payments, 2019–2025

Across 144 payments — averaging $60.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$8K
  • Gilead$222
  • Biosense Webster, Inc.$158
  • Pfizer$149
  • Merz North America, Inc.$91
  • Bristol Myers Squibb$81
  • plus $439 from 12 others
$323,319in research payments, 2019–2025

Across 14 payments — averaging $23,094 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Novartis$216K
  • Amgen$86K
  • E.r. Squibb & Sons, L.L.C.$22K

What the payments were for

  • Food & beverage$8,778100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$8,778 in reported general payments places this provider in the 90th percentile of 7,282 family medicine providers in Florida.

See all family medicine providers in Florida →

Medicare billing

Part B allowed, 2024
$192,054
Medicare patients
444
Services billed
2,262

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Atorvastatin Calcium39$520
Valsartan12$453
Rosuvastatin Calcium27$409
Levothyroxine Sodium30$310
Amlodipine Besylate39$287
Pantoprazole Sodium14$256
Losartan Potassium18$228
Metformin Hcl13$108
Furosemide14$47

Paid to pharmacies, not to this prescriber.

Other family medicine in Delray Beach

See the full list for Florida →

Where these figures come from

Is this you, or does something look wrong? →